Companies / Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc.

Nasdaq: TCRTCIK 1107421FORT LAUDERDALE, FLziopharm.com

Financials · FY2025

Revenue$5.0K
Net income$-4.18M
Total debt$0
Cash$354.0K
Diluted EPS$-2.20
Shares outstanding24.4M

Ownership

24.4M shares outstanding · as of May 15, 2026
0.42%Insiders
Ownership
Insiders0.42%101,671
Institutions0.43%103,860
Public float99.16%24,216,615

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
0.21%50,146
Vieser JaimeDirector
0.16%38,853
Jerman Michael AllenFormerDirector
0.06%15,621
Weis HolgerCEOChief Executive Officer
0.05%12,672

Institutional holders 29

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 12, 2026Weis Holger
CEO
GrantCommon Stock$17.5K+8K
+158.03%
12,672
0.05% of shares
low
Jan 12, 2026Vieser Jaime
Director
GrantCommon Stock$16.9K+6K
+22.03%
32,338
0.13% of shares
low
Apr 29, 2026Vieser Jaime
Director
GrantCommon Stock$16.9K+7K
+20.15%
38,853
0.16% of shares
low
Apr 29, 2026Postma Robert W
Director
GrantCommon Stock$16.2K+6K
+14.30%
50,146
0.21% of shares
low
Jan 12, 2026Postma Robert W
Director
GrantCommon Stock$16.2K+6K
+14.70%
43,872
0.18% of shares
low
Jan 12, 2026Jerman Michael Allen
Director
GrantCommon Stock$15.6K+5K
+129.24%
9,589
0.04% of shares
low
Apr 29, 2026Jerman Michael Allen
Director
GrantCommon Stock$15.6K+6K
+62.91%
15,621
0.06% of shares
low
May 22, 2026Weis Holger
CEO
GrantCommon Stock$8.8K+4K
+305.53%
4,911
0.02% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TCRTCommon StockEquity98973P309BBG000FWCC57